AU5700999A - Enhanced functional expression of g protein-coupled receptors - Google Patents

Enhanced functional expression of g protein-coupled receptors Download PDF

Info

Publication number
AU5700999A
AU5700999A AU57009/99A AU5700999A AU5700999A AU 5700999 A AU5700999 A AU 5700999A AU 57009/99 A AU57009/99 A AU 57009/99A AU 5700999 A AU5700999 A AU 5700999A AU 5700999 A AU5700999 A AU 5700999A
Authority
AU
Australia
Prior art keywords
protein
host cell
receptor
heterologous
cell according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU57009/99A
Other languages
English (en)
Inventor
William Baumbauch
Camelia Birsan
Eileen Marie Kajkowski
Margaret Lai
Bradley Alton Ozenberger
Mark Henry Pausch
Sanford Silverman
Eugene Tseng
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF SE
Original Assignee
BASF SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BASF SE filed Critical BASF SE
Publication of AU5700999A publication Critical patent/AU5700999A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
    • C07K14/395—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts from Saccharomyces
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4722—G-proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Mycology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Endocrinology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU57009/99A 1998-09-01 1999-09-01 Enhanced functional expression of g protein-coupled receptors Abandoned AU5700999A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9870498P 1998-09-01 1998-09-01
US60098704 1998-09-01
PCT/US1999/020011 WO2000012704A2 (en) 1998-09-01 1999-09-01 Enhanced functional expression of g protein-coupled receptors

Publications (1)

Publication Number Publication Date
AU5700999A true AU5700999A (en) 2000-03-21

Family

ID=22270543

Family Applications (2)

Application Number Title Priority Date Filing Date
AU57011/99A Ceased AU756244B2 (en) 1998-09-01 1999-09-01 Methods for improving the function of heterologous G protein-coupled receptors
AU57009/99A Abandoned AU5700999A (en) 1998-09-01 1999-09-01 Enhanced functional expression of g protein-coupled receptors

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU57011/99A Ceased AU756244B2 (en) 1998-09-01 1999-09-01 Methods for improving the function of heterologous G protein-coupled receptors

Country Status (5)

Country Link
EP (2) EP1123391A2 (de)
JP (2) JP2002523091A (de)
AU (2) AU756244B2 (de)
CA (2) CA2343046A1 (de)
WO (2) WO2000012705A2 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6528271B1 (en) 1997-06-05 2003-03-04 Duke University Inhibition of βarrestin mediated effects prolongs and potentiates opioid receptor-mediated analgesia
NZ521696A (en) 2000-04-24 2004-06-25 Wyeth Corp Transgenic animal models for diseases that are regulated by G-protein signalling
WO2002035234A1 (en) * 2000-10-26 2002-05-02 The University Of British Columbia A functional assay for g-protein-coupled receptors based on insect cells
AU2002210982A1 (en) * 2000-11-01 2002-05-15 Yamanouchi Pharmaceutical Co..Ltd. Method of screening antiplatelet
US7018812B2 (en) 2000-11-03 2006-03-28 Duke University Modified G-protein coupled receptors
US7163800B2 (en) 2000-11-03 2007-01-16 Molecular Devices Corporation Methods of screening compositions for G protein-coupled receptor desensitization inhibitory activity
DE10056899A1 (de) * 2000-11-16 2002-05-29 Aventis Pharma Gmbh Promotor zur funktionellen Charakterisierung von G-Protein gekoppelten Rezeptoren in der Hefe Saccharomyces cerevisiae
WO2002045503A2 (en) * 2000-12-06 2002-06-13 Deltagen, Inc. Transgenic mice containing targeted gene disruptions
GB0030038D0 (en) * 2000-12-08 2001-01-24 Univ Warwick Yeast-based assay
US7279324B2 (en) 2001-01-23 2007-10-09 Duke University Nucleic acid encoding G-protein coupled receptor with modified DRY motif
EP1336655A1 (de) * 2002-01-12 2003-08-20 Aventis Pharma Deutschland GmbH Verfahren zur Identifikation von konstitutiv aktiven Mutanten
DE10233516A1 (de) * 2002-07-23 2004-02-12 Aventis Pharma Deutschland Gmbh Verfahren zur Identifizierung von Substanzen
JP4977012B2 (ja) * 2005-03-29 2012-07-18 Ｂｉｏ−ｅｎｅｒｇｙ株式会社 レセプター結合性物質のスクリーニング方法
CN101166527A (zh) 2005-04-27 2008-04-23 艾尼纳制药公司 用于治疗肥胖症和糖尿病以及其相关病况和用于治疗可通过增加血液glp-1含量改善的病况的组合疗法
NZ564759A (en) 2005-06-30 2011-08-26 Prosidion Ltd GPCR agonists
DK1971862T3 (da) 2006-04-11 2011-02-14 Arena Pharm Inc Fremgangsmåder til anvendelse af GPR119-receptor til identificering af forbindelser anvendelige til øgning af knoglemasse hos en person
EP2377863A1 (de) 2007-01-04 2011-10-19 Prosidion Limited Piperidin-GPCR-Agonisten
AR064735A1 (es) 2007-01-04 2009-04-22 Prosidion Ltd Agonistas de gpcr y composicion farmaceutica en base al compuesto
CL2008000017A1 (es) 2007-01-04 2008-08-01 Prosidion Ltd Compuestos derivados de heterociclos de nitrogeno y oxigeno, agonistas de gpcr; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de la obesidad, diabetes, sindrome metabolico, hiperlipidemia, toleranci
CA2681415C (en) * 2007-03-22 2020-11-03 Heptares Therapeutics Limited Mutant g-protein coupled receptors and methods for selecting them
US20100286112A1 (en) 2007-09-10 2010-11-11 Oscar Barba Compounds for the treatment of metabolic disorders
GB0720390D0 (en) 2007-10-18 2007-11-28 Prosidion Ltd G-Protein coupled receptor agonists
GB0720389D0 (en) 2007-10-18 2008-11-12 Prosidion Ltd G-Protein Coupled Receptor Agonists
EP2108960A1 (de) 2008-04-07 2009-10-14 Arena Pharmaceuticals, Inc. Verfahren zur Verwendung eines A G Protein-gekoppelten Rezeptors zur Identifikation von Peptid YY (PYY) Sekretagoga und nützliche Verbindungen zur Behandlung von durch (PYY) Sekretagoga modulierten Zuständen und nützliche Verbindungen zur Behandlung von Zuständen durch PYY
GB0904285D0 (en) 2009-03-12 2009-04-22 Prosidion Ltd Compounds for the treatment of metabolic disorders
GB0904287D0 (en) 2009-03-12 2009-04-22 Prosidion Ltd Compounds for the treatment of metabolic disorders
GB0904284D0 (en) 2009-03-12 2009-04-22 Prosidion Ltd Compounds for the treatment of metabolic disorders
JP7422498B2 (ja) * 2019-07-25 2024-01-26 芳武 村山 ペプチド、細胞遊走抑制剤、細胞浸潤抑制剤、がん細胞転移抑制剤、及び医薬

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5691188A (en) * 1994-02-14 1997-11-25 American Cyanamid Company Transformed yeast cells expressing heterologous G-protein coupled receptor
JPH10502245A (ja) * 1994-06-29 1998-03-03 メルク エンド カンパニー インコーポレーテッド 改変ｇ−蛋白質結合リセプタ
WO1998038217A1 (en) * 1997-02-27 1998-09-03 Milt Teitler Constitutively activated serotonin receptors

Also Published As

Publication number Publication date
CA2344591A1 (en) 2000-03-09
CA2343046A1 (en) 2000-03-09
WO2000012704A3 (en) 2000-11-30
WO2000012705A9 (en) 2000-07-13
AU5701199A (en) 2000-03-21
WO2000012705A3 (en) 2000-10-05
WO2000012704A9 (en) 2000-06-08
WO2000012705A2 (en) 2000-03-09
WO2000012704A2 (en) 2000-03-09
EP1123391A2 (de) 2001-08-16
EP1112359A2 (de) 2001-07-04
AU756244B2 (en) 2003-01-09
JP2002523091A (ja) 2002-07-30
JP2002523090A (ja) 2002-07-30

Similar Documents

Publication Publication Date Title
AU5700999A (en) Enhanced functional expression of g protein-coupled receptors
US6406871B1 (en) Method for detecting ligand binding to G protein coupled receptors
Price et al. Functional coupling of a mammalian somatostatin receptor to the yeast pheromone response pathway
US5482835A (en) Methods of testing in yeast cells for agonists and antagonists of mammal G-protein coupled receptors
US20080153124A1 (en) Methods for improving the function of heterlogous G protein-coupled receptors
Harashima et al. Gα subunit Gpa2 recruits kelch repeat subunits that inhibit receptor-G protein coupling during cAMP-induced dimorphic transitions in Saccharomyces cerevisiae
JP2009143932A (ja) 改変ｇ蛋白質を発現する酵母細胞及びそれらの利用方法
US6509447B1 (en) G protein chimeras and methods of screening compounds
US6291177B1 (en) Assay for agents which alter G-protein coupled receptor activity
WO2002083934A1 (en) P2yac receptor involved in platelet aggregation
Chinault Molecular mechanisms of G protein activation
Landry et al. The git5 Gbeta and git11 Ggamma Form an Atypical Gbetagamma Dimer Acting in the Fission Yeast...

Legal Events

Date Code Title Description
DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 20010702

MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted